Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CytoDyn Inc. | 4,275,000 | reported | 18 Oct 2021 | tx 201+35,373,155−11,971,821 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Oct 2021 | GRANT_AWARD | CytoDyn Inc. | 4,275,000 | 0.00 USD | deriv |
| 06 Aug 2021 | GRANT_AWARD | CytoDyn Inc. | 200,000 | 0.00 USD | |
| 06 Aug 2021 | GRANT_AWARD | CytoDyn Inc. | 75,758 | 0.00 USD | |
| 30 Sept 2020 | GRANT_AWARD | CytoDyn Inc. | 500,000 | — | |
| 30 Sept 2020 | GRANT_AWARD | CytoDyn Inc. | 2,000,000 | 0.00 USD | deriv |
| 31 Jul 2020 | TAX_WITHHOLDING | CytoDyn Inc. | 156,570 | 4.97 USD | |
| 31 Jul 2020 | GRANT_AWARD | CytoDyn Inc. | 323,157 | 0.00 USD | |
| 04 May 2020 | EXERCISE | CytoDyn Inc. | 30,933 | 0.39 USD | |
| 30 Apr 2020 | EXERCISE | CytoDyn Inc. | 152,000 | 0.75 USD | |
| 30 Apr 2020 | SALE | CytoDyn Inc. | 2,219,837 | 3.53 USD | anomaly |
| 30 Apr 2020 | EXERCISE | CytoDyn Inc. | 2,000,000 | 0.63 USD | |
| 30 Apr 2020 | EXERCISE | CytoDyn Inc. | 187,817 | 0.39 USD | |
| 04 May 2020 | SALE | CytoDyn Inc. | 1,201,652 | 2.79 USD | anomaly |
| 30 Apr 2020 | EXERCISE | CytoDyn Inc. | 200,000 | 0.90 USD | |
| 30 Apr 2020 | EXERCISE | CytoDyn Inc. | 325,000 | 0.87 USD | |
| 01 May 2020 | SALE | CytoDyn Inc. | 1,399,685 | 3.26 USD | anomaly |
| 30 Apr 2020 | EXERCISE | CytoDyn Inc. | 600,000 | 1.09 USD | |
| 30 Apr 2020 | EXERCISE | CytoDyn Inc. | 199,800 | 0.57 USD | |
| 30 Apr 2020 | EXERCISE | CytoDyn Inc. | 600,000 | 0.80 USD | |
| 30 Apr 2020 | EXERCISE | CytoDyn Inc. | 116,550 | 0.49 USD | |
| 30 Apr 2020 | EXERCISE | CytoDyn Inc. | 1,000,000 | 0.57 USD | |
| 04 May 2020 | EXERCISE | CytoDyn Inc. | 30,933 | 0.00 USD | deriv |
| 30 Apr 2020 | EXERCISE | CytoDyn Inc. | 2,000,000 | 0.00 USD | deriv |
| 30 Apr 2020 | EXERCISE | CytoDyn Inc. | 187,817 | 0.00 USD | deriv |
| 30 Apr 2020 | EXERCISE | CytoDyn Inc. | 1,000,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 21 Oct 2016.